Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon (Q80568647)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

mesenchymal stem cell

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Ringdén O

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Uzunel M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Sundberg B

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Lönnies L

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Gustafsson J

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Henningsohn L

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Le Blanc K

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

5 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

2271-2276

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17611560%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404833

1 January 2020

exact match

0 references

cites work

Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Characterization of cells with osteogenic potential from human marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Repair of articular cartilage defects using mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Mesenchymal stem cells: heading into the clinic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Risk factors for severe hemorrhagic cystitis following BMT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Hemorrhagic cystitis: a retrospective single-center survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021

Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404833

7 January 2021